StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by johnny007on Nov 24, 2017 3:41pm

73 Views

Post# 27027830

RE:Anonymous net buyer

Reversal confirmation, above daily 20ma and 8ema. Slow but steady.

16c - 20c first base ..

DD has been posted here, I know, hard to find in between the many posts.

PS: Yes sure, the first draw down has happened - and Milost payed +50% on the new shares
after they shorted it all the way down. Hence selling pressure gone and recovery.

Bullboard Posts

How one company is disrupting PoC testing